Log In
BCIQ
Print this Print this
 

Aware BED EIA test

  Manage Alerts
Collapse Summary General Information
Company Calypte Biomedical Corp.
DescriptionIn vitro quantitative enzyme immunoassay (EIA) and estimates incidence by determining the proportion of HIV-1 specific IgG in a given serum, plasma or whole-blood specimen compared to total IgG
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsMeasure HIV-1 incidence in population
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today